期刊文献+

新型佐剂MF59和AS03在流感疫苗中的应用 被引量:1

Application of new generation adjuvants MF59 and AS03 in influenza vaccines
原文传递
导出
摘要 佐剂能增强流感疫苗的免疫效果,除了经典的铝佐剂,一些新型流感疫苗佐剂也已应用于人体,如水包油乳剂MF59、AS03.它们不仅与经典铝佐剂的抗体诱导能力相当,还能诱导特异性细胞免疫应答.此文就流感疫苗新型佐剂的组成、作用机制、临床试验进行总结和分析,并对佐剂研究的进一步发展提出思考和见解. Adjuvants can increase the immune response to influenza vaccines.Besides the classic aluminum adjuvant,several new adjuvants,including MF59 and AS03,have been licensed for human use.They have shown improved efficacy for cell-mediated response,and also have a humoral immunity profile similar to aluminum.This article outlines the composition,mode of action and clinical efficacy of new generation influenza vaccine adjuvants.Thoughts and proposals on further development of adjuvants are also addressed.
作者 刘玉斌 陈则
出处 《国际生物制品学杂志》 CAS 2016年第5期228-232,241,共6页 International Journal of Biologicals
关键词 流感疫苗 佐剂 免疫 组成 作用机制 应用 Influenza vaccines Adjuvants,immunologic Composition Action mechanisms Applications
  • 相关文献

参考文献35

  • 1Lindblad EB, Elhay MJ, Silva R, et al. Adjuvant modulation of immune responses to tuberculosis subunit vaccines [J]. Infect Immun, 1997, 65 (2): 623-629.
  • 2Launay O, Duval X, Fitonssi S, et al. Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adju- vanted H1N1 vaccines: results from two randomised trials [J]. BMC Infect Dis, 2013, 13: 435.
  • 3O' Hagan DT, Ott GS, Nest GV, et al. The history of MF59 adjuvant: a phoenix that arose from the ashes [J]. Expert Rev Vaccines, 2013, 12(1): 13-30.
  • 4Ott G, Barchfeld GL, Chernoff D, et al. MF59. Design and evaluation of a safe and potent adjuvant for human vaccines [J]. Pharm Biotechnol, 1995, 6: 277-296.
  • 5O'Hagan DT, Ott GS, De Gregorio E, et al. The mechanism MF59- an innately attractive adjuvant formulation [J]. Vaccine, 2012, 30(29): 4341-4348.
  • 6Dupuis M, Denis-Mize K, LaBarbara A, et ai. Immunization with the adjuvant MF59 induces macrophage trafficking and apoptosis [J]. Eur J Immunol, 2001, 31 (10):2910-2918.
  • 7Hui G, Hashimoto C. The requirement of CD80, CD86, and ICAM-1 On the ability of adjuvant formulations to potentiate antibody responses to a Plasmodium falciparurn blood-stage vaccine[J]. Vaccine, 2007, 25(51): 8549-8556.
  • 8O'Hagan DT, Rappuoli R, De Gregorio E, et ak MF59 adju- vant: the best insurance against influenza strain diversity [J]. Expert Rev Vaccines, 2011, 10(4) :447-462.
  • 9Seubert A, Monaci E, Pizza M, et al. The adjuvants alumi- num hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells [J]. J Immunol, 2008, 180(8): 5402-5412.
  • 10Calabro S, Tortoli M, Baudner BC, et al. Vaccine adiuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes [J]. Vaccine, 2011, 29 (9): 1812-1823.

同被引文献15

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部